Precipio, Inc.
PRPO
$-0.07
Change (1 day)
$7.30
Year High
$4.31
Year Low
Categories
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Precipio, Inc. (PRPO) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 1.3 M | -386,000 | 3.67 M | 18.1 M | 3.68 M |
| 2022 | 1.04 M | -2,053,000 | 5.14 M | 21.5 M | 5.71 M |
| 2021 | 697 K | -10,238,000 | 5.84 M | 30.44 M | 13.48 M |
| 2020 | 874 K | -1,165,000 | 6.55 M | 20.71 M | 4.2 M |
| 2019 | 574 K | 510 K | 6.31 M | 19.51 M | 1.88 M |